REQUEST A DEMO
Total
USD $0.00
Search more companies

Unitas Pharmaceuticals Private Limited (India)

Main Activities: Office Administrative Services
Full name: Unitas Pharmaceuticals Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Unitas Pharmaceuticals Private Limited is an unlisted company, incorporated on 02/03/1994. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U74899DL1994PTC057671 and registration number is 057671. The company is a trade company, it is engaged in wholesale trading.

Legal Address
R-28, Inderpuri
Central Delhi; Delhi; Postal Code: 110012

Contact Details: Purchase the Unitas Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Unitas Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Unitas Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
March 02, 1994
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Unitas Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-10.29%
Total operating revenue
-10.26%
Operating profit (EBIT)
9.77%
EBITDA
22.89%
Net Profit (Loss) for the Period
1.52%
Total assets
11.7%
Total equity
484.07%
Operating Profit Margin (ROS)
0.42%
Net Profit Margin
0.16%
Return on Equity (ROE)
-393.96%
Debt to Equity Ratio
-4545.1%
Quick Ratio
-0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?